We have a broad range of experience in financial activities across multiple markets
We offer a diverse range of services based on the unique needs of each team we work with, including:
ASSIST COMPANIES IN M&A TRANSACTIONS
Our SPAC (NASDAQ: MBTCU) raised $115M from institutional investors in North America.
Nocturne Acquisition Corp. announced the execution of a definitive business combination agreement with Cognos Therapeutics, Inc., an advanced medical device company focused on creating unique technologies to radically advance the diagnosis and treatment of neuropathic diseases.
The proposed business combination is expected to be completed in the third quarter of 2023.